Clinical Trials Directory

Trials / Completed

CompletedNCT00654290

Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft

Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft, A Prospective Double-Blind Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
All
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation is the most common arrhythmia post coronary bypass surgery, currently B-blockers are the class I indication to prevent AF post CABG. We decide to evaluate use of propranolol and amiodarone separately and together to find a better prophylaxis for AF peri-CABG

Detailed description

In this double blind randomized study 240 consecutive patients underwent elective coronary artery bypass grafting, being randomized prospectively into three groups, propranolol (p) (n=80), amiodarone (A) (n=80) and amiodarone with propranolol (AP) (n=80). All groups received their medications from 7 days preoperatively and continued their medications for 5 days post CABG.

Conditions

Interventions

TypeNameDescription
DRUGAmiodarone + PropranololAmiodarone and Propranolol 7 days pre-operation to 5 days post CABG
DRUGAmiodaroneAmiodarone treated 7 days pre-operation to 5 days post CABG
DRUGPropranololPropranolol from 7 days pre-operation to 5 days post CABG

Timeline

Start date
2007-03-01
Primary completion
2008-01-01
Completion
2008-02-01
First posted
2008-04-07
Last updated
2008-04-07

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00654290. Inclusion in this directory is not an endorsement.